Insider Buy/Sell Ratio for March 2026
Ratio0.2:1
Daily Buy & Sell Volume
By Sector
Healthcare
Buys184
Sells1934
Buy $$246.08M
Sell $$11.25B
Ratio1:45.72
% Change vs. Prior
Ratio -88.2%Value +475.7%
Utilities
Buys16
Sells90
Buy $$933.23K
Sell $$5.32B
Ratio1:5704.90
% Change vs. Prior
Ratio -67.7%Value +270.9%
Technology
Buys117
Sells2544
Buy $$1.23B
Sell $$3.78B
Ratio1:3.06
% Change vs. Prior
Ratio +687.2%Value +54.0%
Energy
Buys83
Sells544
Buy $$24.98M
Sell $$4.03B
Ratio1:161.25
% Change vs. Prior
Ratio -65.2%Value +265.3%
Consumer Defensive
Buys55
Sells276
Buy $$16.33M
Sell $$1.05B
Ratio1:64.34
% Change vs. Prior
Ratio -31.8%Value +62.3%
Industrials
Buys185
Sells787
Buy $$42.23M
Sell $$963.58M
Ratio1:22.82
% Change vs. Prior
Ratio +185.0%Value -74.7%
Financial Services
Buys673
Sells737
Buy $$105.78M
Sell $$658.57M
Ratio1:6.23
% Change vs. Prior
Ratio -6.1%Value -77.6%
Consumer Cyclical
Buys110
Sells541
Buy $$274.83M
Sell $$412.13M
Ratio1:1.50
% Change vs. Prior
Ratio +443.0%Value -56.8%
Basic Materials
Buys60
Sells135
Buy $$53.85M
Sell $$482.73M
Ratio1:8.96
% Change vs. Prior
Ratio -23.0%Value +110.0%
Communication Services
Buys130
Sells267
Buy $$35.47M
Sell $$494.43M
Ratio1:13.94
% Change vs. Prior
Ratio -6.7%Value +63.9%
Real Estate
Buys64
Sells208
Buy $$21.06M
Sell $$111.47M
Ratio1:5.29
% Change vs. Prior
Ratio +103.8%Value -21.7%
By Industry
Medical - Instruments & Supplies
Buys19
Sells56
Buy $$14.52M
Sell $$7.62B
Ratio1:524.54
Independent Power Producers
Buys0
Sells10
Buy $$0.00
Sell $$5.30B
RatioAll Sells
Oil & Gas Exploration & Production
Buys44
Sells155
Buy $$9.01M
Sell $$3.00B
Ratio1:332.44
% Change vs. Prior
Ratio -20.4%Value +691.5%
Medical - Healthcare Information Services
Buys10
Sells89
Buy $$18.63M
Sell $$1.66B
Ratio1:88.90
Software - Application
Buys45
Sells758
Buy $$274.84M
Sell $$849.67M
Ratio1:3.09
Hardware, Equipment & Parts
Buys10
Sells300
Buy $$920.07M
Sell $$197.11M
Ratio4.67:1
% Change vs. Prior
Ratio +84195.1%Value +180.9%
Specialty Retail
Buys24
Sells185
Buy $$139.93M
Sell $$963.24M
Ratio1:6.88
% Change vs. Prior
Ratio +131.9%Value +73.1%
Software - Infrastructure
Buys29
Sells459
Buy $$17.23M
Sell $$814.01M
Ratio1:47.24
% Change vs. Prior
Ratio -47.6%Value +78.8%
Computer Hardware
Buys2
Sells368
Buy $$351.04K
Sell $$793.91M
Ratio1:2261.61
Semiconductors
Buys5
Sells415
Buy $$864.72K
Sell $$718.67M
Ratio1:831.11
% Change vs. Prior
Ratio +1060.1%Value -57.1%
Medical - Diagnostics & Research
Buys11
Sells173
Buy $$3.15M
Sell $$699.29M
Ratio1:221.92
Biotechnology
Buys79
Sells1235
Buy $$62.70M
Sell $$518.51M
Ratio1:8.27
% Change vs. Prior
Ratio -76.3%Value -32.8%
Medical - Distribution
Buys0
Sells18
Buy $$0.00
Sell $$426.55M
RatioAll Sells
Aerospace & Defense
Buys14
Sells297
Buy $$13.82M
Sell $$355.83M
Ratio1:25.75
% Change vs. Prior
Ratio +5860.3%Value -86.4%
Oil & Gas Refining & Marketing
Buys1
Sells73
Buy $$30.31K
Sell $$351.21M
Ratio1:11587.24
Transactions (9840)
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
164
Price
$544.58
Total Value
$89.31K
Shares Held After
130
% of Holdings
55.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
356
Price
$543.22
Total Value
$193.39K
Shares Held After
294
% of Holdings
54.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
600
Price
$542.33
Total Value
$325.40K
Shares Held After
650
% of Holdings
48.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
400
Price
$541.31
Total Value
$216.52K
Shares Held After
1,250
% of Holdings
24.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,240
Price
$539.82
Total Value
$669.37K
Shares Held After
1,650
% of Holdings
42.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
720
Price
$538.94
Total Value
$388.04K
Shares Held After
2,890
% of Holdings
19.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,077
Price
$537.90
Total Value
$579.31K
Shares Held After
3,610
% of Holdings
23.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,772
Price
$536.83
Total Value
$951.27K
Shares Held After
4,687
% of Holdings
27.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,955
Price
$536.02
Total Value
$1.05M
Shares Held After
6,459
% of Holdings
23.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
60
Price
$532.97
Total Value
$31.98K
Shares Held After
8,930
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
640
Price
$532.16
Total Value
$340.58K
Shares Held After
8,990
% of Holdings
6.6%
Claritev Corp (CTEV)
Kim Michael — EVP, Chief Digital Officer
Shares
15,000
Price
$16.50
Total Value
$247.50K
Shares Held After
182,878
% of Holdings
8.2%
AtriCure, Inc. (ATRC)
Doraiswamy Vinayak — Chief Scientific Officer
Shares
5,000
Price
$29.83
Total Value
$149.15K
Shares Held After
96,875
% of Holdings
4.9%
GigaCloud Technology Inc (GCT)
Wu Lei — Director
Shares
26,902
Price
$42.81
Total Value
$1.15M
Shares Held After
240,000
% of Holdings
10.1%
GigaCloud Technology Inc (GCT)
Wu Lei — Director
Shares
3,098
Price
$42.00
Total Value
$130.12K
Shares Held After
266,902
% of Holdings
1.1%
CISCO SYSTEMS, INC. (CSCO)
Subaiya Thimaya K. — EVP, Operations
Shares
1,744
Price
$77.07
Total Value
$134.41K
Shares Held After
156,693
% of Holdings
1.1%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
5,400
Price
$13.43
Total Value
$72.52K
Shares Held After
512,272
% of Holdings
1.0%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
13,660
Price
$12.63
Total Value
$172.53K
Shares Held After
517,672
% of Holdings
2.6%
IonQ, Inc. (IONQ)
Raymond John w — Director
Shares
2,800
Price
$33.34
Total Value
$93.35K
Shares Held After
83,963
% of Holdings
3.2%
Coupang, Inc. (CPNG)
MEHTA NEIL — Director
Shares
3,000,000
Price
$18.68
Total Value
$56.04M
Shares Held After
52,978,114
% of Holdings
5.7%
ACM Research, Inc. (ACMR)
McKechnie Mark — Chief Financial Officer and Treasurer
Shares
564
Price
$46.57
Total Value
$26.27K
Shares Held After
900
% of Holdings
38.5%
ACM Research, Inc. (ACMR)
McKechnie Mark — Chief Financial Officer and Treasurer
Shares
29,348
Price
$45.74
Total Value
$1.34M
Shares Held After
1,464
% of Holdings
95.2%
ACM Research, Inc. (ACMR)
McKechnie Mark — Chief Financial Officer and Treasurer
Shares
8,639
Price
$44.94
Total Value
$388.24K
Shares Held After
30,812
% of Holdings
21.9%
ACM Research, Inc. (ACMR)
McKechnie Mark — Chief Financial Officer and Treasurer
Shares
982
Price
$46.55
Total Value
$45.71K
Shares Held After
900
% of Holdings
52.2%
ACM Research, Inc. (ACMR)
McKechnie Mark — Chief Financial Officer and Treasurer
Shares
47,108
Price
$45.74
Total Value
$2.15M
Shares Held After
1,882
% of Holdings
96.2%
ACM Research, Inc. (ACMR)
McKechnie Mark — Chief Financial Officer and Treasurer
Shares
11,910
Price
$44.89
Total Value
$534.64K
Shares Held After
48,990
% of Holdings
19.6%
NLIGHT, INC. (LASR)
Nias James — Chief Accounting Officer
Shares
1,808
Price
$64.42
Total Value
$116.47K
Shares Held After
93,899
% of Holdings
1.9%
NLIGHT, INC. (LASR)
LINK RAYMOND A — Director
Shares
8,760
Price
$64.42
Total Value
$564.32K
Shares Held After
83,816
% of Holdings
9.5%
Sarepta Therapeutics, Inc. (SRPT)
Mayo Stephen — Director
Shares
7,239
Price
$17.02
Total Value
$123.21K
Shares Held After
1,765
% of Holdings
80.4%
Sphere 3D Corp. (ANY)
Reppas Tiah Norton — Chief Accounting Officer
Shares
6,250
Price
$1.61
Total Value
$10.06K
Shares Held After
12,384
% of Holdings
33.5%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
CARR EDWARD — CHIEF ACCOUNTING OFFICER
Shares
300
Price
$85.53
Total Value
$25.66K
Shares Held After
0
% of Holdings
100.0%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
CARR EDWARD — CHIEF ACCOUNTING OFFICER
Shares
200
Price
$83.38
Total Value
$16.68K
Shares Held After
300
% of Holdings
40.0%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
CARR EDWARD — CHIEF ACCOUNTING OFFICER
Shares
3,865
Price
$82.66
Total Value
$319.48K
Shares Held After
500
% of Holdings
88.5%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Garcia Marino — Director
Shares
900
Price
$85.53
Total Value
$76.98K
Shares Held After
0
% of Holdings
100.0%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
CARR EDWARD — CHIEF ACCOUNTING OFFICER
Shares
23,465
Price
$81.75
Total Value
$1.92M
Shares Held After
4,365
% of Holdings
84.3%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Garcia Marino — Director
Shares
200
Price
$83.38
Total Value
$16.68K
Shares Held After
900
% of Holdings
18.2%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
CARR EDWARD — CHIEF ACCOUNTING OFFICER
Shares
15,852
Price
$80.71
Total Value
$1.28M
Shares Held After
27,830
% of Holdings
36.3%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Garcia Marino — Director
Shares
12,796
Price
$82.60
Total Value
$1.06M
Shares Held After
1,100
% of Holdings
92.1%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Garcia Marino — Director
Shares
65,517
Price
$81.74
Total Value
$5.36M
Shares Held After
13,896
% of Holdings
82.5%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Garcia Marino — Director
Shares
43,505
Price
$80.69
Total Value
$3.51M
Shares Held After
79,413
% of Holdings
35.4%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Randhawa Simrat — EVP, Head of R&D
Shares
33,830
Price
$81.48
Total Value
$2.76M
Shares Held After
0
% of Holdings
100.0%
STAAR SURGICAL CO (STAA)
BROADWOOD PARTNERS, L.P. — Director
Shares
299,432
Price
$18.12
Total Value
$5.42M
Shares Held After
15,807,825
% of Holdings
1.9%
Klaviyo, Inc. (KVYO)
Edmond Landon — Chief Legal Officer
Shares
14,366
Price
$20.15
Total Value
$289.47K
Shares Held After
312,362
% of Holdings
4.4%
Klaviyo, Inc. (KVYO)
Whalen Amanda — Chief Financial Officer
Shares
5,077
Price
$19.34
Total Value
$98.19K
Shares Held After
412,425
% of Holdings
1.2%
Klaviyo, Inc. (KVYO)
Whalen Amanda — Chief Financial Officer
Shares
8,923
Price
$19.72
Total Value
$175.96K
Shares Held After
417,502
% of Holdings
2.1%
Confluent, Inc. (CFLT)
Sivaram Rohan — CHIEF FINANCIAL OFFICER
Shares
29,996
Price
$30.67
Total Value
$919.98K
Shares Held After
531,971
% of Holdings
5.3%
Fox Corp (FOX)
NALLEN JOHN — President, COO
Shares
4,553
Price
$58.08
Total Value
$264.44K
Shares Held After
383,066
% of Holdings
1.2%
Fox Corp (FOX)
NALLEN JOHN — President, COO
Shares
212,253
Price
$57.67
Total Value
$12.24M
Shares Held After
362,206
% of Holdings
36.9%
Fox Corp (FOX)
MURDOCH LACHLAN K — Director
Shares
7,900
Price
$58.06
Total Value
$458.67K
Shares Held After
175,524
% of Holdings
4.3%
Fox Corp (FOX)
MURDOCH LACHLAN K — Director
Shares
239,357
Price
$57.68
Total Value
$13.81M
Shares Held After
183,424
% of Holdings
56.6%
Showing 2551–2600 of 9840 transactions (page 52 of 197)